Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Senesco Technologies has been awarded $244,479 grants from the US government under HR: 3590 - Patient Protection and Affordable Care Act in connection with its multiple myeloma program.
Subscribe to our email newsletter
Senesco president and CEO Leslie Browne said that they are pleased to receive this grant to support continued development of SNS01-T, company’s lead therapeutic candidate for the treatment of multiple myeloma, which is expected to enter human clinical trials in early 2011.
"This award provides non-dilutive funding that will support our efforts to address patient needs in this orphan indication."
Senesco said that it is leveraging proprietary technology that regulates programmed cell death, or apoptosis.